IP Library Granted Patent US 11,134,685
Granted Patent B2
US 11,134,685 · App. 16/776,303 · Granted Oct 5, 2021

Compositions and uses thereof for controlling ectoparasites in non-human mammals

Inventors: Hamadi Karembe (Libourne, FR); Marie Varloud (Libourne, FR)
Assignee: Ceva Santé Animale
A01N51/00A01N47/02A61K31/341A61K31/415
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,134,685
App. No.
16/776,303
Granted
Oct 5, 2021
Kind
B2
Abstract

The invention relates to novel veterinary compositions comprising an effective amount of a neonicotinoid compound and an effective amount of a N-arylpyrazole compound. The invention also relates to the use of such compositions for controlling ectoparasites in a non-human mammal.

Claims (5)

1. A method for controlling fleas in a non-human mammal comprising, administering to the non-human mammal a veterinary composition consisting essentially of an effective amount of dinotefuran or salts thereof and an effective amount of fipronil or salts thereof, wherein the ratio of dinotefuran or salts thereof to fipronil or salts thereof is 1:1.5, and wherein the veterinary composition produces a synergistic effect.

2. The method of claim 1 , wherein the non-human mammal is a dog or a cat.

3. The method of claim 1 , wherein the composition is intended for topical application.

4. The method of claim 1 , wherein the composition is a spot-on, a pour-on, or a line-on composition.

5. A method for treating flea infestations in a non-human mammal, comprising administering to the non-human mammal a veterinary composition consisting essentially of an effective amount of dinotefuran or salts thereof and an effective amount of fipronil or salts thereof, wherein the ratio of dinotefuran or salts thereof to fipronil or salts thereof is 1:1.5, and wherein the veterinary composition produces a synergistic effect.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2020
From: KAREMBE, HAMADI; VARLOUD, MARIE
To: CEVA SANTE ANIMALE
Reel/Frame 052244/0789 →
Priority Claims (1)
EP 15306211 · Jul 24, 2015 · regional
Continuity (2)
Division 15747374
Related Publication 20200163339A1 · May 28, 2020